Competition as a public policy tool: what is the evidence?
Related
From uncertainty to causation: a valuation perspective on life sciences disputes
How do you value a product that may never reach the market? How do you distinguish commercial opportunity from scientific possibility? How do you assess loss in markets shaped by regulation, reimbursement and patient behaviour? These are just some of the valuation questions that arise in life sciences… Read More
< 1 minute read
Podcasts
Modernising EU competition policy: from guidelines to outcomes
This special edition of Top of the Agenda was recorded at our 2026 Brussels conference, which hosted senior figures from the European Commission, national competition authorities, academics and the legal community to discuss one of the most significant developments in EU competition policy in two decades: the revision of… Read More